Top Key Companies for Tumor Multigene Detection Kit Market: Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, NantHealth, Personal Genome Diagnostics, GTH.O.
Global Tumor Multigene Detection Kit Market Size was estimated at USD 538.9 million in 2022 and is projected to reach USD 718.06 million by 2028, exhibiting a CAGR of 4.9% during the forecast period.
Global Tumor Multigene Detection Kit Market Overview And Scope:
The Global Tumor Multigene Detection Kit Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Tumor Multigene Detection Kit utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Tumor Multigene Detection Kit Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Multigene Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tumor Multigene Detection Kit market.
Global Tumor Multigene Detection Kit Market Segmentation
By Type, Tumor Multigene Detection Kit market has been segmented into:
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing
By Application, Tumor Multigene Detection Kit market has been segmented into:
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other
Regional Analysis of Tumor Multigene Detection Kit Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Tumor Multigene Detection Kit Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Tumor Multigene Detection Kit market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Tumor Multigene Detection Kit market.
Top Key Companies Covered in Tumor Multigene Detection Kit market are:
Roche Foundation Medicine
Illumina Inc.
Life Technologies Corporation
Thermo Fisher Scientific
Memorial Sloan Kettering
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
NantHealth
Personal Genome Diagnostics
GTH.O
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Tumor Multigene Detection Kit Market by Type
5.1 Tumor Multigene Detection Kit Market Overview Snapshot and Growth Engine
5.2 Tumor Multigene Detection Kit Market Overview
5.3 Reversible End Termination Sequencing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Reversible End Termination Sequencing: Geographic Segmentation
5.4 Semiconductor Sequencing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Semiconductor Sequencing: Geographic Segmentation
5.5 Combined Probe Anchored Polymerization Sequencing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Combined Probe Anchored Polymerization Sequencing: Geographic Segmentation
Chapter 6: Tumor Multigene Detection Kit Market by Application
6.1 Tumor Multigene Detection Kit Market Overview Snapshot and Growth Engine
6.2 Tumor Multigene Detection Kit Market Overview
6.3 Companion Diagnostics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Companion Diagnostics: Geographic Segmentation
6.4 Early Cancer Screening
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Early Cancer Screening: Geographic Segmentation
6.5 Drug Discovery
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Drug Discovery: Geographic Segmentation
6.6 Other
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Tumor Multigene Detection Kit Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Tumor Multigene Detection Kit Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Tumor Multigene Detection Kit Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ROCHE FOUNDATION MEDICINE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ILLUMINA INC.
7.4 LIFE TECHNOLOGIES CORPORATION
7.5 THERMO FISHER SCIENTIFIC
7.6 MEMORIAL SLOAN KETTERING
7.7 NOVOGENE
7.8 GENESEEQ
7.9 AMOYDX
7.10 BURNING ROCK MEDICINE
7.11 NANTHEALTH
7.12 PERSONAL GENOME DIAGNOSTICS
7.13 GTH.O
Chapter 8: Global Tumor Multigene Detection Kit Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Reversible End Termination Sequencing
8.2.2 Semiconductor Sequencing
8.2.3 Combined Probe Anchored Polymerization Sequencing
8.3 Historic and Forecasted Market Size By Application
8.3.1 Companion Diagnostics
8.3.2 Early Cancer Screening
8.3.3 Drug Discovery
8.3.4 Other
Chapter 9: North America Tumor Multigene Detection Kit Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Reversible End Termination Sequencing
9.4.2 Semiconductor Sequencing
9.4.3 Combined Probe Anchored Polymerization Sequencing
9.5 Historic and Forecasted Market Size By Application
9.5.1 Companion Diagnostics
9.5.2 Early Cancer Screening
9.5.3 Drug Discovery
9.5.4 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Tumor Multigene Detection Kit Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Reversible End Termination Sequencing
10.4.2 Semiconductor Sequencing
10.4.3 Combined Probe Anchored Polymerization Sequencing
10.5 Historic and Forecasted Market Size By Application
10.5.1 Companion Diagnostics
10.5.2 Early Cancer Screening
10.5.3 Drug Discovery
10.5.4 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Tumor Multigene Detection Kit Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Reversible End Termination Sequencing
11.4.2 Semiconductor Sequencing
11.4.3 Combined Probe Anchored Polymerization Sequencing
11.5 Historic and Forecasted Market Size By Application
11.5.1 Companion Diagnostics
11.5.2 Early Cancer Screening
11.5.3 Drug Discovery
11.5.4 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Tumor Multigene Detection Kit Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Reversible End Termination Sequencing
12.4.2 Semiconductor Sequencing
12.4.3 Combined Probe Anchored Polymerization Sequencing
12.5 Historic and Forecasted Market Size By Application
12.5.1 Companion Diagnostics
12.5.2 Early Cancer Screening
12.5.3 Drug Discovery
12.5.4 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Tumor Multigene Detection Kit Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Reversible End Termination Sequencing
13.4.2 Semiconductor Sequencing
13.4.3 Combined Probe Anchored Polymerization Sequencing
13.5 Historic and Forecasted Market Size By Application
13.5.1 Companion Diagnostics
13.5.2 Early Cancer Screening
13.5.3 Drug Discovery
13.5.4 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Tumor Multigene Detection Kit Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Reversible End Termination Sequencing
14.4.2 Semiconductor Sequencing
14.4.3 Combined Probe Anchored Polymerization Sequencing
14.5 Historic and Forecasted Market Size By Application
14.5.1 Companion Diagnostics
14.5.2 Early Cancer Screening
14.5.3 Drug Discovery
14.5.4 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Tumor Multigene Detection Kit Scope:
|
Report Data
|
Tumor Multigene Detection Kit Market
|
|
Tumor Multigene Detection Kit Market Size in 2022
|
USD 538.90 million
|
|
Tumor Multigene Detection Kit CAGR 2023 - 2030
|
4.90%
|
|
Tumor Multigene Detection Kit Base Year
|
2022
|
|
Tumor Multigene Detection Kit Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, NantHealth, Personal Genome Diagnostics, GTH.O.
|
|
Key Segments
|
By Type
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing
By Applications
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other
|
